Germany · Delayed Price · Currency is EUR Redcare Pharmacy NV Statistics
Total Valuation
FRA:SAE1 has a market cap or net worth of EUR 1.32 billion. The enterprise value is 1.46 billion.
| Market Cap | 1.32B |
| Enterprise Value | 1.46B |
Important Dates
The next estimated earnings date is Monday, March 9, 2026.
| Earnings Date | Mar 9, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 13.52% |
| Owned by Institutions (%) | 29.06% |
| Float | 14.05M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.47 |
| PB Ratio | 2.52 |
| P/TBV Ratio | 13.22 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 40.11 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -41.41 |
| EV / Sales | 0.52 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -64.67 |
Financial Position
The company has a current ratio of 1.68, with a Debt / Equity ratio of 0.75.
| Current Ratio | 1.68 |
| Quick Ratio | 1.04 |
| Debt / Equity | 0.75 |
| Debt / EBITDA | 797.56 |
| Debt / FCF | -17.42 |
| Interest Coverage | -1.51 |
Financial Efficiency
Return on equity (ROE) is -6.89% and return on invested capital (ROIC) is -2.17%.
| Return on Equity (ROE) | -6.89% |
| Return on Assets (ROA) | -1.64% |
| Return on Invested Capital (ROIC) | -2.17% |
| Return on Capital Employed (ROCE) | -3.49% |
| Revenue Per Employee | 1.54M |
| Profits Per Employee | -19,259 |
| Employee Count | 1,827 |
| Asset Turnover | 2.52 |
| Inventory Turnover | 13.88 |
Taxes
| Income Tax | -7.46M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -58.27% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -58.27% |
| 50-Day Moving Average | 6.83 |
| 200-Day Moving Average | 9.34 |
| Relative Strength Index (RSI) | 44.94 |
| Average Volume (20 Days) | 1 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, FRA:SAE1 had revenue of EUR 2.82 billion and -35.19 million in losses.
| Revenue | 2.82B |
| Gross Profit | 645.38M |
| Operating Income | -29.38M |
| Pretax Income | -43.84M |
| Net Income | -35.19M |
| EBITDA | -6.49M |
| EBIT | -29.38M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 271.29 million in cash and 392.40 million in debt, giving a net cash position of -121.11 million.
| Cash & Cash Equivalents | 271.29M |
| Total Debt | 392.40M |
| Net Cash | -121.11M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 522.02M |
| Book Value Per Share | n/a |
| Working Capital | 257.47M |
Cash Flow
In the last 12 months, operating cash flow was 32.82 million and capital expenditures -55.34 million, giving a free cash flow of -22.53 million.
| Operating Cash Flow | 32.82M |
| Capital Expenditures | -55.34M |
| Free Cash Flow | -22.53M |
| FCF Per Share | n/a |
Margins
Gross margin is 22.88%, with operating and profit margins of -1.04% and -1.25%.
| Gross Margin | 22.88% |
| Operating Margin | -1.04% |
| Pretax Margin | -1.55% |
| Profit Margin | -1.25% |
| EBITDA Margin | -0.23% |
| EBIT Margin | -1.04% |
| FCF Margin | n/a |
Dividends & Yields
FRA:SAE1 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -2.67% |
| FCF Yield | -1.71% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |